205 related articles for article (PubMed ID: 22391813)
1. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.
Zhang S; Jiang T; Feng L; Sun J; Lu H; Wang Q; Pan M; Huang D; Wang X; Wang L; Jin H
J Mol Med (Berl); 2012 Sep; 90(9):1069-77. PubMed ID: 22391813
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
3. Yin Yang 1 facilitates hepatocellular carcinoma cell lipid metabolism and tumor progression by inhibiting PGC-1β-induced fatty acid oxidation.
Li Y; Kasim V; Yan X; Li L; Meliala ITS; Huang C; Li Z; Lei K; Song G; Zheng X; Wu S
Theranostics; 2019; 9(25):7599-7615. PubMed ID: 31695789
[TBL] [Abstract][Full Text] [Related]
4. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
[TBL] [Abstract][Full Text] [Related]
5. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
6. YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor.
Dong S; Ma X; Wang Z; Han B; Zou H; Wu Z; Zang Y; Zhuang L
Oncotarget; 2017 Jun; 8(25):40583-40593. PubMed ID: 28489564
[TBL] [Abstract][Full Text] [Related]
7. Yin Yang 1 is a multi-functional regulator of adipocyte differentiation in 3T3-L1 cells.
Han Y; Choi YH; Lee SH; Jin YH; Cheong H; Lee KY
Mol Cell Endocrinol; 2015 Sep; 413():217-27. PubMed ID: 26159900
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.
Ko CY; Hsu HC; Shen MR; Chang WC; Wang JM
J Biol Chem; 2008 Nov; 283(45):30919-32. PubMed ID: 18753137
[TBL] [Abstract][Full Text] [Related]
9. YY1 Complex Promotes Quaking Expression via Super-Enhancer Binding during EMT of Hepatocellular Carcinoma.
Han J; Meng J; Chen S; Wang X; Yin S; Zhang Q; Liu H; Qin R; Li Z; Zhong W; Zhang C; Zhang H; Tang Y; Lin T; Gao W; Zhang X; Yang L; Liu Y; Zhou HG; Sun T; Yang C
Cancer Res; 2019 Apr; 79(7):1451-1464. PubMed ID: 30760518
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
Xuan W; Zhou C; You G
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32249890
[TBL] [Abstract][Full Text] [Related]
11. Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin.
Meng J; Han J; Wang X; Wu T; Zhang H; An H; Qin L; Sun Y; Zhong W; Yang C; Liu H; Sun T
Pharmacol Res; 2023 Feb; 188():106661. PubMed ID: 36669583
[TBL] [Abstract][Full Text] [Related]
12. Molecular interplay between linc01134 and YY1 dictates hepatocellular carcinoma progression.
Rong Z; Wang Z; Wang X; Qin C; Geng W
J Exp Clin Cancer Res; 2020 Apr; 39(1):61. PubMed ID: 32272940
[TBL] [Abstract][Full Text] [Related]
13. The Yin and Yang of YY1 in tumor growth and suppression.
Khachigian LM
Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic relevance of CP2c and YY1 expression in hepatocellular carcinoma.
Kim JS; Son SH; Kim MY; Choi D; Jang IS; Paik SS; Chae JH; Uversky VN; Kim CG
Oncotarget; 2017 Apr; 8(15):24389-24400. PubMed ID: 28412749
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activation of the tumor suppressor, HLJ1, by the transcription factors YY1 and activator protein 1.
Wang CC; Tsai MF; Dai TH; Hong TM; Chan WK; Chen JJ; Yang PC
Cancer Res; 2007 May; 67(10):4816-26. PubMed ID: 17510411
[TBL] [Abstract][Full Text] [Related]
16. Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression.
Liu H; Han J; Lv Y; Zhao Z; Zheng S; Sun Y; Sun T
J Nanobiotechnology; 2023 Jul; 21(1):208. PubMed ID: 37408047
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Yin Yang 1 by Tyrosine Phosphorylation.
Wang GZ; Goff SP
J Biol Chem; 2015 Sep; 290(36):21890-900. PubMed ID: 26198631
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus protein up-regulated HLJ1 expression via the transcription factor YY1 in human hepatocarcinoma cells.
Zhang L; Cai X; Chen K; Wang Z; Wang L; Ren M; Huang A; Tang H
Virus Res; 2011 Apr; 157(1):76-81. PubMed ID: 21345358
[TBL] [Abstract][Full Text] [Related]
19. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
Xu XP; Peng XQ; Yin XM; Liu Y; Shi ZY
Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
[TBL] [Abstract][Full Text] [Related]
20. HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway.
Wang L; Gao Y; Zhao X; Guo C; Wang X; Yang Y; Han C; Zhao L; Qin Y; Liu L; Huang C; Wang W
Cell Prolif; 2020 Aug; 53(8):e12835. PubMed ID: 32557953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]